🔍

MANALIPETC - Manali Petrochem

📊 NSE: MANALIPETC 🏢 Petrochemicals 📅 Last Updated: 12/14/2025 9:31

📢 Recent Corporate Announcements

Manali Petrochemicals Subsidiary PennWhite India Inaugurates New Manufacturing Facility in Chennai

🟢 POSITIVE ⭐ 8/10

EXPANSION 📅 29 Apr 2026, 04:22 PM

Manali Petrochemicals' step-down subsidiary, PennWhite India, has successfully inaugurated its new manufacturing facility in Oragadam, Chennai. The plant was commissioned within 18 months of the land lease agreement and is designed to manufacture foam control chemistry for the Indian and Asian markets. This facility localizes the production of PennWhite UK's specialty chemical range, which MPL acquired in November 2022. The plant has already secured ISO 9001 certification and aims to replicate UK manufacturing standards locally.

New manufacturing facility inaugurated at Oragadam, Chennai, for foam control chemistry.
Plant commissioned within 18 months of the land lease agreement executed in early 2025.
Facility is ISO 9001 certified and serves as a strategic hub for the wider Asian market.
Strategic localization of PennWhite UK's portfolio, which includes over 200 specialty chemical products.
Follows the 2022 acquisition of PennWhite UK and the 2024 incorporation of the Indian subsidiary.

💡 Investors should monitor the revenue contribution from this new facility as it scales up to serve the Asian market. The move into high-margin specialty chemicals via localized production is a positive long-term growth driver for MPL.

Manali Petrochemicals Resumes Plant-1 Operations After Government Propylene Allocation

🟢 POSITIVE ⭐ 7/10

REGULATORY 📅 20 Apr 2026, 12:53 PM

Manali Petrochemicals has announced the phased resumption of operations at its Plant-1 in Chennai starting April 20, 2026. This follows a suspension of operations since March 12, 2026, caused by a total cessation of propylene supply from CPCL. The restart is enabled by a revised government allocation of a fixed daily quantity of propylene specifically to meet pharmaceutical industry requirements. While Plant-1 is restarting, the status quo remains for Plant-2 as per previous communications.

Resumption of Plant-1 operations in Chennai effective April 20, 2026, after a 39-day suspension.
Department of Pharmaceuticals has allocated a fixed daily quantity of propylene to be supplied by CPCL.
The allocation is specifically designated to meet the requirements of the Pharma Industry.
Operations will resume in a phased manner as feedstock supplies are received.
Plant-2 remains under previous status quo conditions with no immediate change in operational status.

💡 Investors should view this as a positive step toward restoring production capacity, though full normalcy depends on the status of Plant-2 and consistent feedstock supply.

Manali Petrochemicals Receives Madras HC Order on Long-Standing Labor Wage Disputes

🔵 WATCH ⭐ 6/10

LEGAL 📅 02 Apr 2026, 02:33 PM

Manali Petrochemicals Limited (MANALIPETC) has announced that the Madras High Court has disposed of writ petitions related to labor disputes dating back to 2004 and 2006. These petitions challenged Industrial Tribunal awards concerning wage revisions and service conditions for workmen. The company received the court order on March 31, 2026, and is currently assessing the financial and legal implications. The final impact on the company's balance sheet or profit and loss statement is yet to be quantified.

Madras High Court disposed of Writ Petitions 5850, 5851 of 2016 and 2731 of 2023 on March 25, 2026.
The case involves Industrial Tribunal awards I.D. No. 35 of 2006 and I.D. No. 51 of 2004.
Disputes pertain to long-standing wage revision and service conditions of the company's workmen.
Company is currently evaluating the financial and legal implications with counsel to determine the next steps.

💡 Investors should monitor for further disclosures regarding the specific financial liability arising from this court order. A significant retroactive wage revision could impact short-term profitability and cash flows.

Manali Petrochemicals Wins ₹3.83 Crore Customs Duty Dispute; CESTAT Rules in Favor

🟢 POSITIVE ⭐ 6/10

LEGAL 📅 02 Apr 2026, 12:25 PM

Manali Petrochemicals Limited has received a favorable final order from CESTAT regarding a customs duty dispute dating back to July 2019. The tribunal set aside a demand of ₹3.83 crore plus interest which was originally levied due to the alleged misclassification of imported Quicklime. The ruling confirmed the company's classification was correct as the product purity (91%-95%) was below the 98% threshold required for the higher duty category. The company is now assessing the financial impact of writing back the provisions previously made for this liability.

CESTAT set aside a customs duty demand of ₹3.83 crore plus interest.
The dispute involved the classification of Quicklime imports under CTI 2522 1000 versus CTI 2825 9090.
Tribunal ruled in favor of the company as the Calcium Oxide purity was between 91% and 95%.
The company will assess the write-back of provisions made for this demand, which will positively impact the bottom line.

💡 Investors should view this as a positive development that clears a long-standing legal liability and will likely result in a one-time boost to profits through a provision reversal. Monitor the next quarterly earnings for the specific financial impact of this write-back.

Manali Petrochemicals Wins ₹3.83 Crore Customs Duty Dispute; CESTAT Sets Aside Demand

🟢 POSITIVE ⭐ 6/10

LEGAL 📅 01 Apr 2026, 05:58 PM

Manali Petrochemicals has received a favorable final order from CESTAT regarding a customs duty dispute dating back to 2019. The tribunal set aside a demand of ₹3.83 crore plus interest related to the alleged misclassification of imported Quicklime. The ruling confirmed that the company's classification was correct as the Calcium Oxide purity (91%-95%) was below the 98% threshold required for the higher duty category. The company is now assessing the financial impact of writing back the provisions previously made for this liability.

CESTAT set aside a customs duty demand of ₹3.83 crore plus interest in its entirety.
The dispute involved the classification of Quicklime imports under CTI 2522 1000 versus CTI 2825 9090.
Tribunal ruled in favor of the company as the purity of goods (91%-95%) did not meet the 98% threshold for higher duty.
The company will assess and likely write back provisions made for this liability, boosting future net profit.

💡 This is a positive development that removes a long-standing legal liability and will likely lead to a one-time gain via provision reversal. Investors should look for the specific financial impact in the upcoming quarterly earnings report.

Manali Petrochemicals: Madras High Court Disposes Writ Petitions on Wage Revision Case

🔵 WATCH ⭐ 6/10

LEGAL 📅 31 Mar 2026, 06:21 PM

Manali Petrochemicals has received a common order from the Madras High Court regarding long-standing industrial disputes from 2004 and 2006. The court has disposed of the company's writ petitions which challenged previous tribunal awards concerning wage revisions and service conditions for workmen. The company is currently assessing the financial and legal implications of this order with its legal counsel. Investors should be aware that this could lead to potential back-pay liabilities or increased operational costs once the impact is quantified.

Madras High Court disposed of Writ Petitions W.P. Nos. 5850, 5851 of 2016 and 2731 of 2023 on March 25, 2026.
The legal dispute pertains to Industrial Tribunal awards in I.D. Nos. 35 of 2006 and 51 of 2004.
The core issue involves wage revision and service conditions for the company's workmen dating back over two decades.
Company is currently evaluating the financial impact and will take appropriate steps as advised by counsel.

💡 Investors should monitor for subsequent disclosures regarding the specific financial liability or provisions the company may need to make. The scale of the impact will depend on the extent of wage arrears and revised service terms mandated by the court order.

Manali Petrochemicals Reports Dematerialization of 8,550 Shares (Feb 16-28, 2026)

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 25 Mar 2026, 06:12 PM

Manali Petrochemicals Limited has filed its periodic report regarding the dematerialization and rematerialization of shares for the period of February 16 to February 28, 2026. The company processed a total of 8,550 shares across 18 folios and 27 certificates during this timeframe. This filing is a standard compliance requirement under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The activity involves both NSDL and CDSL depositories.

Total of 8,550 shares were dematerialized or rematerialized during the period.
The reporting period spans from February 16, 2026, to February 28, 2026.
A total of 18 folios and 27 share certificates were involved in the process.
Submission made in compliance with SEBI (Depositories and Participants) Regulations, 2018.

💡 This is a routine administrative disclosure with no impact on company fundamentals; no action is required from investors.

Manali Petrochemicals Reports Dematerialization of 4,800 Shares in February 2026

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 25 Mar 2026, 06:05 PM

Manali Petrochemicals Limited has filed its routine compliance report under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The filing details the dematerialization of shares for the period between February 1, 2026, and February 15, 2026. A total of 4,800 shares were processed during this window across 22 distinct folios. This is a standard administrative disclosure and does not reflect any change in the company's operational or financial status.

Total of 4,800 equity shares dematerialized during the reporting period.
The report covers the first half of February 2026 (Feb 1 to Feb 15).
A total of 22 folios and 22 share certificates were involved in the process.
Compliance submitted in accordance with SEBI (Depositories and Participants) Regulations, 2018.

💡 This is a routine regulatory filing with no impact on stock valuation; investors do not need to take any action.

Manali Petrochemicals Announces Trading Window Closure from March 31, 2026

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 25 Mar 2026, 04:37 PM

Manali Petrochemicals Limited has informed the exchanges that its trading window will be closed for designated persons starting March 31, 2026. This closure is a routine regulatory requirement under SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of the announcement of audited financial results for the quarter and year ending March 31, 2026. The window will remain closed until 48 hours after the financial results are officially disclosed. The specific date for the board meeting to approve these results will be announced at a later date.

Trading window for designated persons to close effective March 31, 2026.
Closure pertains to the audited financial results for the quarter and year ending March 31, 2026.
Window will reopen 48 hours after the disclosure of the financial results to the stock exchanges.
Board meeting date for the approval of results is yet to be determined and will be intimated later.

💡 This is a standard regulatory filing and does not impact the company's fundamentals. Investors should monitor for the upcoming board meeting date and subsequent financial results.

Manali Petrochemicals Designates A R Swamydurai as Senior Management Personnel

🟡 NEUTRAL ⭐ 3/10

MANAGEMENT 📅 09 Mar 2026, 06:20 PM

Manali Petrochemicals Limited has designated Mr. A R Swamydurai, the current Deputy General Manager (Operations), as a Senior Management Personnel effective March 9, 2026. Mr. Swamydurai is a company veteran who joined as an ESS trainee in 1989, bringing approximately 37 years of internal experience to the senior role. He currently leads operations across both of the company's manufacturing plants. This internal promotion suggests a focus on operational continuity and leveraging deep-rooted technical expertise within the organization.

Mr. A R Swamydurai designated as Senior Management Personnel effective March 9, 2026
Appointee has over 36 years of experience with the company, having joined in 1989
Currently serves as DGM (Operations) overseeing both manufacturing plants
Holds a diploma in Chemical Technology and rose through the ranks from a trainee position

💡 This is a routine internal promotion and does not necessitate any immediate change in investment strategy. Investors should view this as a move to maintain operational stability.

Manali Petrochemicals: CARE Reaffirms A+ Stable Rating for ₹125 Crore Bank Facilities

🟡 NEUTRAL ⭐ 4/10

ROUTINE 📅 26 Feb 2026, 06:57 PM

CARE Ratings Limited has reaffirmed the credit ratings for Manali Petrochemicals Limited's bank facilities totaling ₹125 crore. The long-term facilities of ₹75 crore and the combined long/short-term facilities of ₹25 crore both maintained a 'CARE A+; Stable' rating. The short-term facilities of ₹25 crore were reaffirmed at 'CARE A1+'. This reaffirmation indicates that the company maintains a stable financial profile and a strong ability to service its debt obligations.

CARE A+; Stable rating reaffirmed for ₹75.00 crore long-term bank facilities
CARE A1+ rating reaffirmed for ₹25.00 crore short-term bank facilities
Combined long-term and short-term facilities of ₹25.00 crore reaffirmed at CARE A+; Stable / CARE A1+
Total bank facilities covered under the rating action amount to ₹125.00 crore

💡 The reaffirmation of credit ratings suggests financial stability; investors should maintain their positions while monitoring the company's quarterly margin performance.

Manali Petrochemicals Wins 30-Year Legal Battle; Rs 10.82 Cr Claim Dismissed

🟢 POSITIVE ⭐ 6/10

LEGAL 📅 13 Feb 2026, 05:17 PM

Manali Petrochemicals Limited has received a favorable judgment in a long-standing civil suit filed by Unimark Remedies Ltd. in 1995. The suit sought damages and specific performance regarding a 1995 MOU, with a claim value of Rs 10.82 crore plus interest. The Hon’ble City Civil Court, Mumbai, dismissed the suit in favor of the company on February 11, 2026. This resolution effectively removes a decades-old contingent liability from the company's financial outlook.

Mumbai City Civil Court dismissed the 1995 civil suit filed by Unimark Remedies Ltd.
The legal dispute involved a claim of Rs 10.82 crore plus additional interest.
The case originated from a Memorandum of Understanding (MOU) dated May 17, 1995.
The ruling eliminates a potential financial liability that has been pending for over 30 years.
The company was formerly known as U.B. Petroproducts Ltd. during the time of the initial filing.

💡 Investors should view this as a positive development that clears a long-term legal overhang and protects the company's cash flows from a potential payout. No immediate action is required, but it improves the overall risk profile of the stock.

Manali Petrochemicals Receives Rs 5.22 Lakh Income Tax Penalty for AY 2017-18

🟡 NEUTRAL ⭐ 3/10

LEGAL 📅 09 Feb 2026, 06:45 PM

Manali Petrochemicals Limited has received a penalty order of Rs 5.22 lakh from the Income Tax Department under Section 270A for the Assessment Year 2017-18. The penalty is related to the disallowance of certain expenditures previously claimed by the company. The company had already filed an appeal with the Madras High Court in July 2025 regarding the underlying tax demand, which is still pending. Management has clarified that this order will not have any material impact on the company's financial or operational performance.

Penalty of Rs 5,22,035 imposed by the Income Tax Department for AY 2017-18.
Penalty arises from the disallowance of certain expenditure items.
Company has a pending appeal in the Madras High Court filed in July 2025 regarding the primary tax demand.
Management states there is no material impact on financials, operations, or other activities.

💡 No action is required as the penalty amount is insignificant compared to the company's scale. Investors should treat this as a routine legal update regarding historical tax assessments.

Manali Petrochemicals Q3 Consolidated PAT Jumps to Rs 68.43 Cr Aided by Subsidiary Sale

🟢 POSITIVE ⭐ 7/10

EARNINGS 📅 02 Feb 2026, 07:32 PM

Manali Petrochemicals reported a consolidated PAT of Rs 68.43 crore for the quarter ended December 2025, a sharp rise from Rs 18.15 crore in the preceding quarter. The total consolidated income stood at Rs 266.80 crore, showing steady growth from Rs 260.94 crore. A key driver for the profit surge was the gain on disposal of a UK subsidiary, alongside consistent performance from other international units. Standalone PBT also improved to Rs 5.09 crore, reflecting better operational efficiencies compared to the previous quarter's Rs 0.19 crore.

Consolidated PAT increased to Rs 68.43 crore in Q3 FY26 from Rs 18.15 crore in Q2 FY26.
Total consolidated income grew to Rs 266.80 crore compared to Rs 260.94 crore in the previous quarter.
Standalone PBT improved significantly to Rs 5.09 crore from Rs 0.19 crore on a quarter-on-quarter basis.
Profitability was significantly boosted by a one-time gain from the disposal of a UK subsidiary.
Management remains focused on cost optimization and product mix to counter macro-economic uncertainty.

💡 Investors should note that the substantial profit surge is largely due to a non-recurring gain from a subsidiary sale. Focus on the recovery in standalone margins and core petrochemical demand in upcoming quarters to assess long-term value.

Manali Petrochemicals Q3 Net Profit Rises to ₹4.55 Cr; Revenue Up 38% YoY

🟢 POSITIVE ⭐ 8/10

EARNINGS 📅 02 Feb 2026, 03:50 PM

Manali Petrochemicals reported a significant turnaround in Q3 FY26, posting a net profit of ₹4.55 crore compared to a loss of ₹2.83 crore in the same quarter last year. Revenue from operations grew 38% year-on-year to ₹195.14 crore, reflecting improved operational performance. The company navigated several exceptional items, including a ₹45.87 lakh gain from land sale and a ₹33.62 lakh provision for new labour codes. While inventory insurance claims from Cyclone Michaung are settled, a substantial ₹12.26 crore claim for property damage remains under assessment by insurers.

Revenue from operations increased 38% YoY to ₹195.14 crore in Q3 FY26.
Net profit stood at ₹4.55 crore, recovering from a net loss of ₹2.83 crore in the year-ago period.
Profit Before Tax (PBT) reached ₹5.09 crore, despite a net exceptional loss of ₹1.41 crore during the quarter.
Insurance claims of ₹12.26 crore for property, plant, and equipment damage are still pending final assessment.
Lease renewal for the Unit-II manufacturing site remains pending with the Government of Tamil Nadu since 2017.

💡 The company has demonstrated a strong recovery in profitability and revenue growth, suggesting a cyclical upturn. Investors should monitor the final settlement of the ₹12.26 crore insurance claim and the status of the Unit-II lease renewal for long-term operational stability.

View All MANALIPETC Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

Consolidated revenue declined 13.18% YoY to INR 921.63 Cr in FY25. Standalone revenue fell 18.58% to INR 669.27 Cr. The Propylene Glycol (PG) segment maintained stable demand in pharma and food sectors, but Slabstock Polyol witnessed a notable decline in volume and value due to intensified price competition from low-cost imports.

Geographic Revenue Split

The company has expanded its presence in Europe through the acquisition of Penn-White Limited (UK). Subsidiaries now contribute a major portion of consolidated profits, with investments in subsidiaries forming approximately 40% of the tangible net worth. Strategic focus is on Nordics, mainland Europe, and MENA regions.

Profitability Margins

Consolidated Profit After Tax (PAT) margin improved to 3.18% (INR 29.31 Cr) in FY25 from 1.81% (INR 19.21 Cr) in FY24. Standalone operations are at breakeven margins, with a PAT loss of INR 8.74 Cr in FY25. CARE Ratings notes that operating margins remaining below 8% on a consistent basis is a negative rating factor.

EBITDA Margin

Consolidated EBITDA for Q1 FY25 included INR 10.6 Cr from standalone operations and INR 5.7 Cr from Penn-White. Standalone EBITDA margin was approximately 6% in Q1 FY25, while Penn-White achieved a significantly higher margin of 24.7% on its INR 23 Cr turnover.

Capital Expenditure

Total additions to fixed assets in FY25 amounted to INR 15.99 Cr. Planned capital expenditure includes a West India greenfield project with a modeled IRR of 30%, PG capacity expansion (20.7% IRR), and Polyester Polyol expansion (23% IRR).

Credit Rating & Borrowing

CARE Ratings assigned 'CARE A+; Stable' for long-term bank facilities and 'CARE A1+' for short-term facilities. The company maintains a low level of long-term debt with a comfortable interest coverage ratio of 5.10x in FY24 and >2x in Q1 FY25.

⚙️ Operational Drivers

Raw Materials

Primary raw materials include Propylene and Propylene Oxide (PO). Propylene is the base feedstock, with global capacity increasing by 11 MTA in 2023, primarily in China.

Import Sources

The company faces significant pressure from low-cost imports and dumping from China and Thailand, particularly in the industrial and fragrance grades of Propylene Glycol.

Capacity Expansion

Penn-White production capacity is 6,000 MTPA. Standalone capacity utilization was low at 15.39% for the 12 months ended August 2024, while subsidiaries operate at 50-60% capacity.

Raw Material Costs

Raw material prices are volatile and restrict profit margins. Brent Crude oil prices above $76/barrel impact the cost of propylene-based feedstocks. The company is focusing on alternate vendor management to balance production costs.

Manufacturing Efficiency

Average capacity utilization remained low at 15.39% as of August 2024. The company is shifting focus toward strategic project management and energy optimization to improve efficiency.

📈 Strategic Growth

Expected Growth Rate

2.30%

Growth Strategy

Growth will be achieved through a proactive strategic shift toward differentiation and specialty chemicals (currently 37% of portfolio). Key projects include the West India greenfield expansion (30% IRR) and the Econic MoU (signed 2021) to produce CO2-based polyols, turning waste CO2 into economic potential.

Products & Services

Propylene Glycol (Pharma, Food, Fragrance, Industrial grades), Polyols (Slabstock), Specialty Polyols, Foam Control Agents, Release Agents, and Specialty Cast Polyurethanes.

Brand Portfolio

Manali Petrochemicals, Penn-White, and Notedome (Note: Notedome is being divested to strengthen liquidity).

New Products/Services

New product launches include CO2-based polyols through the Econic partnership and specialty cast polyurethanes for subsea, automotive, and defense applications.

Market Expansion

Targeting expansion in the Nordics, mainland Europe, and MENA regions through strategic distribution agreements and the Penn-White acquisition.

Strategic Alliances

Signed a Memorandum of Understanding (MoU) in 2021 with Econic for a two-phase project to produce sustainable polyols using captured CO2.

🌍 External Factors

Industry Trends

The industry is currently at the bottom of the cycle due to increased Chinese capacity and softening downstream demand. Future direction involves a shift toward sustainability and eco-efficiency (CO2-based polyols).

Competitive Landscape

Dominated by global integrated players who enjoy benefits of scale. Manali competes by focusing on the premium end of the market and specialty chemicals.

Competitive Moat

Durable advantages include a 5-year product guarantee (USP) and being the first responder to quality queries from drug control authorities. Technical service intimacy and a large portfolio of tailored specialty products create high switching costs.

Macro Economic Sensitivity

Highly sensitive to global propylene capacity (11 MTA increase in 2023) and Brent Crude oil prices (>$76), which dictate the bottom-of-the-cycle trajectory for earnings.

Consumer Behavior

Softening demand in downstream sectors like Slabstock Polyol has been observed, while demand remains stable in pharma and personal care segments.

Geopolitical Risks

Trade barriers and the potential for government intervention via Anti-Dumping Duties (ADD) on Chinese and Thai imports are critical for protecting domestic market share.

⚖️ Regulatory & Governance

Industry Regulations

Operations are governed by SEBI Listing Regulations 2015 and the Companies Act 2013. The company relies on government support for Anti-Dumping Duties (ADD) to counter unfair import competition.

Environmental Compliance

The company is investing in energy optimization and CO2 capture technology to turn waste into economic potential, aligning with ESG standards.

Taxation Policy Impact

The consolidated tax rate for FY25 was approximately 30.3% (INR 12.74 Cr provision on INR 42.05 Cr PBT).

Legal Contingencies

The company has complied with provisions relating to the Internal Complaints Committee under the Sexual Harassment of Women at Workplace Act. No specific pending court case values were disclosed.

⚠️ Risk Analysis

Key Uncertainties

Aggressive dumping practices from China and Thailand pose a significant risk to margins, with potential impacts on profitability if Anti-Dumping Duties are not maintained.

Geographic Concentration Risk

Significant profit contribution from UK-based subsidiaries (Penn-White and Notedome), with investments in these entities representing 40% of tangible net worth.